[6/29 held webinar] Introducing new functions of drug discovery support AI "Cascade Eye" that visualizes and structures relationships between complex genes and molecules
In the drug discovery process, searching for a target requires work such as "searching for a needle in hay" to search for limited information from a huge amount of paper data.However, it is difficult to perform comprehensive analysis by searching for information by humans, which has become a major issue in recent years.
In this webinar, FRONTEO's drug discovery support AI program that can visualize and structure information on molecules and genes related to the disease to be analyzed in the form of a pathway map (route map showing the relationship) based on a huge amount of paper information. Introducing "Cascade Eye" including new features. Cascade Eye is an AI program that visualizes the relationships between genes and molecules, and is useful for discovering new action mechanisms and indications that are difficult to notice when searching for articles.
In addition, the research team will also demonstrate the product in this webinar, so you can imagine the function more concretely.
◆ Theme: Introducing new functions of drug discovery support AI "Cascade Eye" that visualizes and structures the relationships between complex genes and molecules
◆ Date: May 2022, 6 (Wednesday) 29: 12-10: 12
・ Those who think that the drug discovery process will be streamlined with AI
・ Those involved in drug discovery research
◆ Participation conditions: Those who use free addresses, those who are in the same industry as our company, and those whose affiliation is unknown are not allowed to apply.When accessing ZOOM on the day of the event, please enter the name and email address you provided when you applied for the ZOOM participation input field.
After serving as a manager in the food industry, such as store management, he entered the healthcare industry.He is involved in drug and infusion sales at multiple pharmaceutical companies.He has experienced a wide range of disease areas such as cardiovascular, respiratory, skin and metabolic endocrine areas. She joined FRONTEO and proposes AI solutions mainly to pharmaceutical companies.
Articles in the same category
[Webinar held on August 8] Code of conduct as a listed company when an accounting error is discovered
[Webinar held on August 8] Encourage employees to report fraud-Consideration through corporate scandals where whistle-blowing did not work-
[Webinar held on August 8] "International Arbitration" -Why Japanese companies have "anxiety" about international arbitration
[Webinar held on 7/28] The key points of antitrust law practice for persons in charge of legal affairs and general affairs departments
[Webinar held on 7/14] AI-based support tool for new strategy formulation "Word ATLAS" -Non-biased competitive analysis and visualization of KOL trends-
[7/14 Webinar] The latest information on the enforcement and procurement of US patents
[Webinar held on 7/7] Labor issues associated with remote work-Points of labor management and investigation in case of emergency-
[6/29 held webinar] AI visualizes customer's voice! The 2nd VOC utilization course will be held due to its popularity!
FRONTEO AI Innovation Forum 2022 held
-Realistic problem-solving that can be realized only with natural language AI Fairness of information society created by innovative AI-
Commonly viewed articles
Chugai Pharmaceutical Co., Ltd. has been posted as an introductory user.
FRONTEO's finance in NHK Close-up Gendai + "How to protect your assets? -Prescription for the ultra-low interest rate era-" broadcast on 10/30 ...
Comprehensive support for marriage activities using artificial intelligence KIBIT at the NHK special "Artificial Intelligence Angel or Devil 9" broadcast on 15/2018 ...
FRONTEO has been entrusted with an empirical research project utilizing artificial intelligence in the 30 JPO open call for participants project, following last year.